Pharmacy Faculty Recognized by AACP
Assistant Professor Ana Hincapie, PhD, has been recognized by the American Association of Colleges of Pharmacy (AACP) with the Best Social and Administrative Sciences Research Publication Award for her research: "Relationship between Patients' Perceptions of Care Quality and Health Care Errors in 11 Countries: A Secondary Data Analysis.
The purpose of the study, says Hincapie, was to evaluate the association between patients perceived health care quality and self-reported medical, medication, and laboratory errors in a multinational sample of 11 countries, as measured from survey data from the 2010 Commonwealth Fund International Health Policy Survey.
The award was established to recognize publication of high quality scholarship in the areas of discovery, integration, or application by members of the Social and Administrative Sciences Section at the AACP.
Hincapie was in attendance at the July 16, 2017, meeting to receive her award.
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.